ABG
MRNS

Ally Bridge Group’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Ally Bridge Group’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-394,773
Closed -$3.57M – 32
2024
Q1 		$3.57M Buy
+394,773
New +$3.57M 1.98% 20
2023
Q3 		– Sell
-390,418
Closed -$4.24M – 24
2023
Q2 		$4.24M Buy
+390,418
New +$4.24M 5.14% 9